Federated Investors Inc. PA Invests $10.09 Million in Albireo

... Bank of New York Mellon Corp purchased a new stake in shares of Albireo in the 4th quarter valued at $216,000. Ardsley Advisory Partners bought a new stake in Albireo during the 4th quarter valued at $289,000. Northern Trust Corp raised its holdings ...
https://www.americanbankingnews.com/2018/05/29/federated-investors-inc-pa-invests-10-09-million-in-albireo-albo.html

Heartland Advisors Inc. Takes Position in Albireo

... quarter. Bank of New York Mellon Corp bought a new stake in Albireo in the 4th quarter worth approximately $216,000. Ardsley Advisory Partners bought a new stake in Albireo in the 4th quarter worth approximately $289,000. Finally, Millennium ...
https://www.americanbankingnews.com/2018/05/28/heartland-advisors-inc-takes-position-in-albireo-albo.html

Reviewing Acorda Therapeutics

... and Brigham and Women's Hospital, Inc. Acorda Therapeutics, Inc. was founded in 1995 and is headquartered in Ardsley, New York. Mateon Therapeutics, Inc., a biopharmaceutical company, focuses on the development of vascular disrupting agents for ...
https://www.americanbankingnews.com/2018/05/27/reviewing-acorda-therapeutics-acor-and-mateon-therapeutics-matn.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+AmericanBankingNews+%28American+Banking+News%29

Financial Review: Acorda Therapeutics

... and Brigham and Women's Hospital, Inc. Acorda Therapeutics, Inc. was founded in 1995 and is headquartered in Ardsley, New York. TRACON Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and ...
https://www.americanbankingnews.com/2018/05/26/financial-review-acorda-therapeutics-acor-versus-tracon-pharmaceuticals-tcon.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+AmericanBankingNews+%28American+Banking+News%29

MuleSoft (MULE) Shares Bought by Artisan Partners Limited Partnership

... shares of the company's stock valued at $780,000 after acquiring an additional 11,936 shares during the period. Ardsley Advisory Partners bought a new stake in shares of MuleSoft during the 4th quarter valued at $465,000. Finally, Bank of New York ...
https://www.americanbankingnews.com/2018/05/26/mulesoft-mule-shares-bought-by-artisan-partners-limited-partnership.html

Zacks: Brokerages Anticipate TherapeuticsMD Inc (TXMD) Will Post Quarterly Sales of $4.13 Million

... of the company's stock worth $175,001,000 after buying an additional 3,095,804 shares during the last quarter. Ardsley Advisory Partners lifted its position in shares of TherapeuticsMD by 4,100.0% during the 4th quarter. Ardsley Advisory Partners ...
https://sportsperspectives.com/2018/05/24/zacks-brokerages-anticipate-therapeuticsmd-inc-txmd-will-post-quarterly-sales-of-4-13-million.html

This Westchester Locale Ranks Highest For Best Place To Raise A Family

... on top, at fourth overall with A+ grades across the board. Others that made the cut include Rye (sixth overall), Ardsley (eighth), Scarsdale (11), Chappaqua (15), Hastings-on-Hudson (17), Larchmont (22) and Irvington (25). Hi! You've read our ...
http://cortlandt.dailyvoice.com/lifestyle/this-westchester-locale-ranks-highest-for-best-place-to-raise-a-family/737206/

Albireo (ALBO) Receives Consensus Rating of "Buy" from Analysts

... Capital Management LLC acquired a new stake in Albireo in the first quarter valued at approximately $335,000. Ardsley Advisory Partners acquired a new stake in Albireo in the fourth quarter valued at approximately $289,000. Finally, Northern Trust ...
https://www.americanbankingnews.com/2018/05/18/albireo-albo-receives-consensus-rating-of-buy-from-analysts.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+AmericanBankingNews+%28American+Banking+News%29

TherapeuticsMD Sees Unusually Large Options Volume

... of the company's stock valued at $175,001,000 after purchasing an additional 3,095,804 shares in the last quarter. Ardsley Advisory Partners increased its holdings in TherapeuticsMD by 4,100.0% during the 4th quarter. Ardsley Advisory Partners now ...
https://www.americanbankingnews.com/2018/05/16/therapeuticsmd-sees-unusually-large-options-volume-txmd.html

Acorda Therapeutics (ACOR) versus Seattle Genetics (SGEN) Critical Comparison

... and Brigham and Women's Hospital, Inc. Acorda Therapeutics, Inc. was founded in 1995 and is headquartered in Ardsley, New York. Seattle Genetics, Inc., a biotechnology company, focuses on the development and commercialization of targeted ...
https://www.americanbankingnews.com/2018/05/15/acorda-therapeutics-acor-versus-seattle-genetics-sgen-critical-comparison.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+AmericanBankingNews+%28American+Banking+News%29

Iteris (ITI) Stock Rating Lowered by ValuEngine

... technology company's stock valued at $5,419,000 after buying an additional 214,097 shares during the last quarter. Ardsley Advisory Partners bought a new stake in shares of Iteris during the fourth quarter valued at approximately $1,220,000. Royce & ...
https://www.dailypolitical.com/2018/05/14/iteris-iti-stock-rating-lowered-by-valuengine.html

BVF Inc. IL Purchases New Stake in Albireo

... York Mellon Corp bought a new position in shares of Albireo in the fourth quarter valued at approximately $216,000. Ardsley Advisory Partners bought a new position in shares of Albireo in the fourth quarter valued at approximately $289,000. ...
https://sportsperspectives.com/2018/05/12/bvf-inc-il-purchases-new-stake-in-albireo-albo.html

Iteris, Inc. (ITI) Receives Consensus Rating of "Buy" from Brokerages

... of the technology company's stock worth $5,419,000 after purchasing an additional 214,097 shares during the period. Ardsley Advisory Partners bought a new position in Iteris in the 4th quarter worth $1,220,000. HL Financial Services LLC bought a new ...
https://www.americanbankingnews.com/2018/05/09/iteris-inc-iti-receives-consensus-rating-of-buy-from-brokerages.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+AmericanBankingNews+%28American+Banking+News%29

FY2020 EPS Estimates for TherapeuticsMD Inc Lowered by Oppenheimer

... of the company's stock worth $175,001,000 after buying an additional 3,095,804 shares during the last quarter. Ardsley Advisory Partners grew its stake in TherapeuticsMD by 4,100.0% during the 4th quarter. Ardsley Advisory Partners now owns ...
https://www.americanbankingnews.com/2018/05/07/fy2020-eps-estimates-for-therapeuticsmd-inc-lowered-by-oppenheimer-txmd.html

Albireo (ALBO) Downgraded by BidaskClub

... last quarter. Bank of New York Mellon Corp acquired a new position in Albireo during the 4th quarter worth $216,000. Ardsley Advisory Partners acquired a new position in Albireo during the 4th quarter worth $289,000. Millennium Management LLC lifted ...
https://www.dailypolitical.com/2018/05/05/albireo-albo-downgraded-by-bidaskclub.html

Millennium Management LLC Raises Holdings in Albireo

... last quarter. Bank of New York Mellon Corp acquired a new position in Albireo in the 4th quarter valued at $216,000. Ardsley Advisory Partners acquired a new position in Albireo in the 4th quarter valued at $289,000. Sectoral Asset Management Inc ...
https://sportsperspectives.com/2018/05/05/millennium-management-llc-raises-holdings-in-albireo-albo.html